FAQ: Branded Legacy Subsidiary Partnership with McMaster University

What is the main purpose of the partnership between Branded Legacy and McMaster University?

The partnership aims to evaluate innovative products for populations affected by addictions by combining McMaster’s expertise in addiction medicine and clinical trials with Bio-Legacy’s real-world scientific experience to advance rigorous evaluations and support development of accessible interventions.

Which subsidiary of Branded Legacy is involved in this partnership?

Bio-Legacy Evaluative Group, a wholly owned subsidiary of Branded Legacy, Inc., is the entity partnering with McMaster University.

What specific expertise does McMaster University bring to this collaboration?

McMaster University contributes expertise in addiction medicine, clinical trials, and guideline development to the partnership.

What are the primary goals of this collaborative effort?

The collaboration aims to reduce overdose deaths, minimize drug-related harms, promote long-term recovery, and develop accessible, cost-effective interventions for addiction-affected populations.

What is Branded Legacy’s core business focus?

Branded Legacy is a holdings company focused on health and wellness solutions, specifically developing innovative approaches to combat addiction by preventing overdoses and supporting recovery.

What patented technology does Branded Legacy mention in relation to addiction treatment?

Branded Legacy has a patented intranasal naloxone delivery device that enhances accessibility and dosing precision for opioid overdose treatment.

What additional applications does Branded Legacy’s platform enable beyond addiction treatment?

The platform also enables nasal delivery of vaccines and other medications, creating opportunities in global markets for rapid pandemic response and improved access in underserved regions.

Where can readers find more information about Branded Legacy, Inc.?

More information is available on the company’s website at https://BrandedLegacy.com.

Where can I view the full press release about this partnership?

The full press release can be viewed at https://ibn.fm/8ojxr.